On ECHEMI
Home > Drugs > Affective disorders
Affective disorders
Also known as affective disorders and mood disorders. Previously known as affective psychoses. It is a group of mental disorders with significant and persistent high or low emotions as the main clinical feature, often accompanied by corresponding changes in thinking and behavior. The manifestations of affective disorders vary greatly. Milder ones may be a reaction to some negative life events, while severe ones may become a serious recurrent or even chronic disabling disorder. Severe cases may have psychotic symptoms such as hallucinations and delusions. They often recur, most of which can be relieved, and a few have residual symptoms or become chronic. The first onset age of this type of mental disorder is mostly between 16 and 30 years old. Clinically, it can be divided into four types: depressive episodes, manic episodes, bipolar disorders, and persistent mood disorders.
  • Site of disease:

    psychology
  • Infectious :

    Not contagious
  • Frequent population:

    All groups
  • Related symptoms:

    Hallucinations Delirium Auditory hallucinations Irritability Schizotypal personality disorder
  • Concurrent disease:

Related Drugs
Olanzapine orally disintegrating tablets
Indication: 1. Olanzapine is suitable for the treatment of schizophrenia. 2. For patients who respond to the initial treatment with olanzapine, consolidation treatment can effectively maintain clinical symptom improvement. 3. Olanzapine is suitable for the treatment of moderate to severe manic episodes. 4. For patients with manic episodes who respond to olanzapine treatment, olanzapine can prevent the recurrence of bipolar disorder.
Olanzapine orally disintegrating tablets
Indication: 1. Olanzapine is suitable for the treatment of schizophrenia. 2. For patients who respond to the initial treatment with olanzapine, consolidation treatment can effectively maintain clinical symptom improvement. 3. Olanzapine is suitable for the treatment of moderate to severe manic episodes. 4. For patients with manic episodes who respond to olanzapine treatment, olanzapine can prevent the recurrence of bipolar disorder.
Olanzapine orally disintegrating tablets
Indication: 1. Olanzapine is suitable for the treatment of schizophrenia. 2. For patients who respond to the initial treatment with olanzapine, consolidation treatment can effectively maintain clinical symptom improvement. 3. Olanzapine is suitable for the treatment of moderate to severe manic episodes. 4. For patients with manic episodes who respond to olanzapine treatment, olanzapine can prevent the recurrence of bipolar disorder.
Olanzapine Tablets
Indication: For the treatment of schizophrenia, olanzapine can maintain its clinical effect during maintenance treatment in patients who respond to initial treatment.
Magnesium valproate tablets
Indication: It is used to treat various types of epilepsy. It can also be used to treat manic episodes of bipolar disorder.
Manufacturer:

Hunan Xiangzhong Pharmaceutical Co., Ltd.

Nicergoline for injection
Indication: 1. Improve the low will and emotional disorders caused by the sequelae of cerebral infarction (slow sensation, lack of concentration, memory loss, lack of ideas, depression, anxiety, etc.). 2. Acute and chronic peripheral circulatory disorders (limb vascular occlusive disease, Raynaud's syndrome, other symptoms of poor peripheral circulation).
Manufacturer:

Beijing SL Pharmaceutical Co., Ltd.

Nicergoline for injection
Indication: 1. Improve the low will and emotional disorders caused by the sequelae of cerebral infarction (slow sensation, lack of concentration, memory loss, lack of ideas, depression, anxiety, etc.). 2. Acute and chronic peripheral circulatory disorders (limb vascular occlusive disease, Raynaud's syndrome, other symptoms of poor peripheral circulation).
Manufacturer:

Chengdu Tiantai Mountain Pharmaceutical Co., Ltd.

Nicergoline for injection
Indication: 1. Improve the low will and emotional disorders caused by the sequelae of cerebral infarction (slow sensation, lack of concentration, memory loss, lack of ideas, depression, anxiety, etc.). 2. Acute and chronic peripheral circulatory disorders (limb vascular occlusive disease, Raynaud's syndrome, other symptoms of poor peripheral circulation).
Manufacturer:

Dandong Yichuang Pharmaceutical Co., Ltd.

Nicergoline for injection
Indication: 1. Improve the low will and emotional disorders caused by the sequelae of cerebral infarction (slow sensation, lack of concentration, memory loss, lack of ideas, depression, anxiety, etc.). 2. Acute and chronic peripheral circulatory disorders (limb vascular occlusive disease, Raynaud's syndrome, other symptoms of poor peripheral circulation).
Manufacturer:

Jiuquan Dadeli Pharmaceutical Co., Ltd.

Nicergoline for injection
Indication: 1. Improve the low will and emotional disorders caused by the sequelae of cerebral infarction (slow sensation, lack of concentration, memory loss, lack of ideas, depression, anxiety, etc.). 2. Acute and chronic peripheral circulatory disorders (limb vascular occlusive disease, Raynaud's syndrome, other symptoms of poor peripheral circulation).
Manufacturer:

Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.